Javascript must be enabled to continue!
Prevalence of hypertensive retinopathy in hypertensive patients
View through CrossRef
Hypertension manifests in the eyes as retinopathy, choroidopathy and optic neuropathy of which retinopathy can be used as a predictor for systemic morbidities and mortalities. The objective of the study was to determine the prevalence of retinopathy in hypertensive patients and determine the correlation of retinopathy with parameters like age, sex, duration of hypertension, severity of hypertension and control of hypertension. This was a cross-sectional, retrospective study done in patients attending our hospital between January to March 2019 comprising of 200 patients. The grading of retinopathy was done using Keith-Wagner-Barker system. The presence of retinopathy was compared with parameters like age, sex and duration of hypertension. Statistical analysis was done using MS-Excel and Chi-square test. Among the 200 hypertensive patients (117 males, 83 females), 57 patients had retinopathy (28.5%) of which 35 were males and 22 were females. Among patients with retinopathy, 32 had Grade 1, 16 had Grade 2, 8 had Grade 3 and 1 had Grade 4 retinopathy. Based on the severity of hypertension, 8 out of 61 patients having mild hypertension, 25 out of 81 patients had moderate hypertension and 24 out of 58 patients having severe hypertension, had retinopathy. The prevalence of retinopathy was higher in patients with hypertension for 5 years or more (54.4%) than those with hypertension with less than 5 years (21.8%). Our study showed prevalence of hypertensive retinopathy to be 28.5%. Severity of hypertension and duration of hypertension > 5 years was found to have an association with hypertensive retinopathy.
GP Innovations Pvt. Ltd.
Title: Prevalence of hypertensive retinopathy in hypertensive patients
Description:
Hypertension manifests in the eyes as retinopathy, choroidopathy and optic neuropathy of which retinopathy can be used as a predictor for systemic morbidities and mortalities.
The objective of the study was to determine the prevalence of retinopathy in hypertensive patients and determine the correlation of retinopathy with parameters like age, sex, duration of hypertension, severity of hypertension and control of hypertension.
This was a cross-sectional, retrospective study done in patients attending our hospital between January to March 2019 comprising of 200 patients.
The grading of retinopathy was done using Keith-Wagner-Barker system.
The presence of retinopathy was compared with parameters like age, sex and duration of hypertension.
Statistical analysis was done using MS-Excel and Chi-square test.
Among the 200 hypertensive patients (117 males, 83 females), 57 patients had retinopathy (28.
5%) of which 35 were males and 22 were females.
Among patients with retinopathy, 32 had Grade 1, 16 had Grade 2, 8 had Grade 3 and 1 had Grade 4 retinopathy.
Based on the severity of hypertension, 8 out of 61 patients having mild hypertension, 25 out of 81 patients had moderate hypertension and 24 out of 58 patients having severe hypertension, had retinopathy.
The prevalence of retinopathy was higher in patients with hypertension for 5 years or more (54.
4%) than those with hypertension with less than 5 years (21.
8%).
Our study showed prevalence of hypertensive retinopathy to be 28.
5%.
Severity of hypertension and duration of hypertension > 5 years was found to have an association with hypertensive retinopathy.
Related Results
Prevalence and Determinants of Hypertensive Retinopathy Ii Nondiabetic CKD Patients
Prevalence and Determinants of Hypertensive Retinopathy Ii Nondiabetic CKD Patients
Background: Hypertensive retinopathy is a common microvascular complication of chronic hypertension and may reflect systemic vascular damage in patients with chronic kidney disease...
Prevalence and Awareness of Diabetic Retinopathy among Known Diabetic Patients Visiting the Sagarmatha Chaudhary Eye Hospital, Lahan
Prevalence and Awareness of Diabetic Retinopathy among Known Diabetic Patients Visiting the Sagarmatha Chaudhary Eye Hospital, Lahan
Introduction: Diabetic retinopathy causes irreversible blindness. Most of the patients visiting the hospital have no signs and symptoms until too late for effective treatment. Earl...
Management of diabetic retinopathy in pregnancy
Management of diabetic retinopathy in pregnancy
Introduction The onset and development of diabetic retinopathy are more common during pregnancy. Pregnancy has no long-term effect on diabetic retinopathy; however, in 50-70% of ca...
Retinopathy in type 2 diabetic patients with microalbuminuria
Retinopathy in type 2 diabetic patients with microalbuminuria
Objective: To determine the prevalence of retinopathy in type 2 diabetic patients with micoalbuminuria and to evaluate the association of risk factors with prevalence of retinopath...
Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients
Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients
AbstractAim The aim of the study was to determine whether there is familialclustering of diabetic retinopathy among South Indian Type 2 diabeticsubjects.Methods During the period S...
Correlation of eGFR‐defined Chronic Kidney Disease Stages with Retinopathy Grades Among Hypertensive, Diabetic and CombinedPathology Patients
Correlation of eGFR‐defined Chronic Kidney Disease Stages with Retinopathy Grades Among Hypertensive, Diabetic and CombinedPathology Patients
Background: Microvascular injury underlies both chronic kidney disease (CKD) and retinopathy, yet the relationship between declining renal function and retinal changes across hyper...
An Observational Study to Validate the Relationship Between Hypertensive Retinopathy and Dehaprakruti
An Observational Study to Validate the Relationship Between Hypertensive Retinopathy and Dehaprakruti
What is good for health and what is to be avoided is very important to stay healthy and this acceptance and rejection is depends on our own constitution i.e., Dehaprakruti as the P...
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
1
Jose F.
Tellez‐Zenteno,
1
Scott B.
Patten, and
1
Samuel
Wiebe
...

